Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - D-A-CH

D-A-CH

In 2024, the Digestives & Intestinal Remedies market market in D-A-CH (Germany, Austria, Switzerland) generated a revenue of US$1.04bn.
It is projected to experience an annual growth rate of 1.85% (CAGR 2024-2029).
When compared globally, in China leads the market, generating a revenue of US$4,408.00m in 2024.
On a per capita basis, the revenue generated in the Digestives & Intestinal Remedies market market in D-A-CH amounted to US$10.27 in 2024.
In Germany, the Digestives & Intestinal Remedies market is driven by a strong demand for natural and herbal products.

Key regions: Canada, United States, Australia, Brazil, Japan

Market

Region

Region comparison

Currency

Analyst Opinion

The Digestives & Intestinal Remedies market in D-A-CH is experiencing steady growth, driven by customer preferences for natural and holistic remedies, increasing awareness of digestive health, and a growing aging population.

Customer preferences: Customers in the D-A-CH region are increasingly seeking natural and holistic remedies for digestive issues. They are becoming more conscious of the ingredients and potential side effects of pharmaceutical products, leading them to opt for herbal or homeopathic remedies instead. This shift in preferences is driving the demand for natural digestive remedies in the market.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in D-A-CH is the rising awareness of digestive health. Consumers are becoming more educated about the importance of maintaining a healthy digestive system and the impact it has on overall well-being. As a result, there is a growing demand for products that promote digestive health, such as probiotics and dietary supplements.Another trend in the market is the increasing aging population in the D-A-CH region. As people age, they are more prone to digestive issues such as indigestion, heartburn, and constipation. This demographic shift is driving the demand for digestive remedies tailored to the specific needs of older adults, such as laxatives and antacids.

Local special circumstances: Germany is the largest market for Digestives & Intestinal Remedies in the D-A-CH region. The country has a strong tradition of herbal medicine and homeopathy, which influences customer preferences for natural remedies. German consumers are particularly receptive to products that are backed by scientific research and have a long-standing reputation for efficacy.Switzerland, on the other hand, has a strong pharmaceutical industry and a high level of trust in conventional medicine. While there is still a demand for natural remedies, pharmaceutical products dominate the market in Switzerland. Swiss consumers prioritize quality and efficacy when choosing digestive remedies.Austria, being geographically located between Germany and Switzerland, has a market that is influenced by both countries. Austrian consumers show a preference for natural remedies but also trust pharmaceutical products. This creates a diverse market with opportunities for both herbal and pharmaceutical digestive remedies.

Underlying macroeconomic factors: The Digestives & Intestinal Remedies market in D-A-CH is also influenced by macroeconomic factors. The region has a stable economy and a high standard of living, which allows consumers to prioritize their health and well-being. Additionally, the D-A-CH region has a well-developed healthcare system, which provides access to a wide range of digestive remedies.In conclusion, the Digestives & Intestinal Remedies market in D-A-CH is driven by customer preferences for natural and holistic remedies, increasing awareness of digestive health, and a growing aging population. The market is influenced by local special circumstances, such as the strong tradition of herbal medicine in Germany and the trust in pharmaceutical products in Switzerland. Overall, the stable economy and well-developed healthcare system in the D-A-CH region support the growth of the Digestives & Intestinal Remedies market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.